{
    "Case ID": "091661",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent infringement dispute between brand-name and generic drug manufacturers"
    ],
    "Legal_Issue": [
        "Whether the generic drug manufacturers infringed the '380 Patent for lovastatin"
    ],
    "Governing_Law": [
        "Patented Medicines (Notice of Compliance) Regulations, Sections 5 and 6"
    ],
    "Procedural_Stage": [
        "Judicial review"
    ],
    "Evidence_Assessment": [
        "Evidence showed significant yield improvements using Coniothyrium fuckelii alone; sterilization procedures were adequate"
    ],
    "Decision_Outcome": [
        "Applications for prohibition orders dismissed"
    ],
    "Burden_of_Proof": [
        "On the applicants to show that non-infringement allegations are unjustified"
    ],
    "Credibility_Factor": [
        "Applicants' contamination argument rejected based on scientific evidence"
    ],
    "Legal_Rule": [
        "Section 5 and 6 of the Patented Medicines (Notice of Compliance) Regulations govern allegations of non-infringement and prohibition orders"
    ],
    "Standard_of_Review": [
        "Balance of probabilities"
    ],
    "Procedural_Issue": [
        "Judicial review under the Patent Act and associated regulations"
    ],
    "Grounds_for_Claim": [
        "Merck Frosst claimed generic manufacturers would infringe their patent for producing lovastatin"
    ],
    "Outcome_on_Merits": [
        "Non-infringement allegations justified; Merck's applications dismissed"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Applications dismissed"
    ],
    "Review_Standard": [
        "Balance of probabilities"
    ],
    "Procedural_Fairness_Assessment": [
        "Process followed regulatory requirements; burden properly allocated"
    ],
    "Key_Evidence_Considered": [
        "Yield data from Coniothyrium fuckelii; adequacy of sterilization procedures"
    ],
    "Legal_Framework": [
        "Patent Act and Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Applicant_Challenge": [
        "Challenging the validity of non-infringement allegations by generics"
    ],
    "Court_Result": [
        "In favor of respondents (generic manufacturers)"
    ],
    "Legal_Rule_Source": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Contamination claim rejected; non-infringement supported by evidence"
    ],
    "Evidence_Type": [
        "Scientific and process-based evidence"
    ],
    "Remedy_Requested": [
        "Prohibition orders against generic manufacturers"
    ],
    "Outcome": [
        "Applications dismissed; costs awarded to respondents"
    ],
    "Decision_Authority": [
        "Federal Court or relevant judicial body under Canadian patent law"
    ],
    "Remedy_Sought": [
        "Prevention of market entry of generic lovastatin until patent expiry"
    ],
    "Resolution_Mechanism": [
        "Judicial review"
    ],
    "Legal_Provision": [
        "Sections 5 and 6, Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Authority": [
        "Patent Act, Canadian intellectual property law"
    ],
    "Claimant_Status": [
        "Merck Frosst as patent holder"
    ],
    "Legal_Provision_Cited": [
        "Section 5 and Section 6 of the Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Allegation of non-infringement based on microbial contamination was unsupported"
    ],
    "Applicable_Process": [
        "Notice of Compliance (NOC) proceedings"
    ],
    "Outcome_of_Review": [
        "Dismissal of applicant's claims"
    ],
    "Pending_Relief_or_Application": [
        "Prohibition order applications"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ]
}